Trading Update and Growth Plan

Summary by AI BETAClose X

Metir plc provided a trading update ahead of its financial year end, reporting increasing demand for its Microtox® LX instruments and reagents, with sales in line with expectations, though production is nearing capacity. The company is discussing increased manufacturing rates for 2026 to reduce delivery times and build stock, alongside plans to upgrade LX and FX units to improve margins. Robust sales of Sulphate Reducing Bacteria (SRB) kits are also noted, with a key component upgrade planned for Q4 to maximize high-margin sales in January 2026. Following the Qatar project's final commissioning of 27 CTM units, a deferred payment of £198k is due by Q1 2026, with a potential £50k performance payment. Metir is also targeting the Saudi Arabian market, a significant opportunity for water-safety technologies. As of December 1, 2025, the Group's cash balance was £147k, with current receivables at £317k, and the company expresses confidence in sufficient projected revenue and cash resources for the foreseeable future, though EBITDA profitability is expected to be deferred into 2026 due to planned investments.

Disclaimer*

Companies

Metir plc (MET)
UK 100

Latest directors dealings